KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Vertex Pharmaceuticals (VRTX) over the last 15 years, with Q4 2025 value amounting to $77.4 million.

  • Vertex Pharmaceuticals' Change in Inventory fell 4752.54% to $77.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $524.2 million, marking a year-over-year increase of 133.38%. This contributed to the annual value of $524.2 million for FY2025, which is 133.38% up from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Change in Inventory of $77.4 million as of Q4 2025, which was down 4752.54% from $131.1 million recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Change in Inventory ranged from a high of $182.5 million in Q3 2024 and a low of -$2.0 million during Q1 2022
  • For the 5-year period, Vertex Pharmaceuticals' Change in Inventory averaged around $79.7 million, with its median value being $77.9 million (2022).
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Change in Inventory crashed by 10877.19% in 2022, and later skyrocketed by 423000.0% in 2023.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Change in Inventory stood at $27.0 million in 2021, then soared by 190.0% to $78.3 million in 2022, then dropped by 10.6% to $70.0 million in 2023, then surged by 110.71% to $147.5 million in 2024, then crashed by 47.53% to $77.4 million in 2025.
  • Its Change in Inventory was $77.4 million in Q4 2025, compared to $131.1 million in Q3 2025 and $148.6 million in Q2 2025.